F

Fresenius Medical Care

Operates dialysis facilities and renal care

Head of Market Access and Government Affairs

Full-TimeUpdated on 10/15/2026Deadline 12/31/26
No salary listed
Expert
Shanghai, China
Hybrid
Growth & MarketingPR & Communications

About the job

Requirements
  • At least 15 years of experience in market access, government affairs, public affairs, or healthcare policy.
  • Significant experience in the medical device or broader healthcare sector.
  • Deep understanding of the China healthcare ecosystem.
  • Proven leadership engaging national and provincial authorities.
  • Strong experience shaping policy within regulated healthcare industries.
  • Demonstrated success leading external engagement for multinational organizations.
  • Strong English communication skills.
Responsibilities
  • Define and execute an integrated market access strategy across the China kidney care portfolio.
  • Lead pricing, reimbursement, and health policy strategies supporting the company's product portfolio ecosystem.
  • Assess the impact of national and provincial healthcare reforms on business performance.
  • Develop access strategies addressing reimbursement pathway optimization, tender access, centralized procurement, volume-based purchasing, public hospital policy shifts, and health technology evaluation.
  • Embed market access priorities into annual commercial planning.
  • Build trusted relationships with key external stakeholders.
  • Represent company interests in policy dialogue and institutional engagements.
  • Anticipate policy developments affecting pricing, reimbursement, and procurement.
  • Lead advocacy initiatives in partnership with industry associations and external stakeholders.
  • Develop policy positions and strategic recommendations for country leadership.
  • Lead strategic external engagement to strengthen institutional positioning in China.
  • Build an executive engagement framework with key government and healthcare stakeholders.
  • Coordinate high-level official visits involving global leadership and regional executives.
  • Lead preparation for senior government meetings, policy forums, and external leadership events.
  • Drive strategic participation in healthcare development initiatives, renal care policy programs, public-private partnerships, and industry coalitions.
  • Enhance the company's visibility as a strategic partner in advancing kidney care in China.
  • Advise the China leadership team on policy-related business risk.
  • Establish structured policy monitoring and intelligence systems.
  • Provide early-warning analysis on policy changes affecting market access, reimbursement, pricing, and procurement models.
  • Lead scenario planning for policy shifts.
  • Shape strategic response plans across business functions.
  • Partner effectively with peer commercial functions to maximize market execution.
  • Ensure strong collaboration to support customer access, clinical adoption, and sales growth.
Desired Qualifications
  • Prior experience in multinational matrix organizations is strongly preferred.

About the company

F

Fresenius Medical Care

View

Fresenius Medical Care North America runs a network of dialysis facilities and outpatient labs to deliver coordinated kidney care for hundreds of thousands of patients. It also offers specialty pharmacy and laboratory services and manufactures a wide range of dialysis equipment, disposables, and renal drugs. The company treats patients by providing dialysis and related care at its clinics, supported by the equipment, supplies, and medicines it develops and distributes. FMCNA differentiates itself through its size and integration as the world's largest fully integrated renal company, with a nationwide network covering care delivery, drugs, labs, and manufacturing, aiming to provide high-quality, convenient access to comprehensive services across North America.

Company Size

11-50

Company Stage

Late Stage VC

Total Funding

$40.2M

Headquarters

Waltham, Massachusetts

Founded

1996

Get referred to Fresenius Medical Care

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Q2 2026 operating income rose 23%, showing transformation gains reached profitability.
  • FME25+ delivered EUR 67 million savings in Q2 2026 and targets EUR 1.2 billion.
  • Real-world evidence studies in July and August 2026 strengthen high-volume hemodiafiltration adoption.

What critics are saying

  • The August 2026 outlook disappointed investors after dialysis growth stalled and shares fell 10%.
  • FME25+ closed around 100 U.S. clinics in 2026, risking patient leakage to DaVita.
  • AB 290 litigation and premium-assistance rules threaten U.S. reimbursement economics and legal spend.

What makes Fresenius Medical Care unique

  • Fresenius Medical Care controls dialysis care, equipment, labs, and specialty pharmacy end-to-end.
  • Its 5008X CAREsystem reached around 100 clinics and 100,000 treatments by May 2026.
  • kinexus and TherapyWise deepen its software moat across home dialysis and kidney therapy.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Professional Development Budget
  • Conference Attendance Budget
  • Flexible Work Hours

Growth & Insights and Company News

Headcount

6 month growth

-3%

1 year growth

-3%

2 year growth

-3%
Business Wire
Mar 28th, 2024
Compsych Corporation Announces 2023 Health At Work Award Winners

CHICAGO--(BUSINESS WIRE)--ComPsych® Corporation, the world’s largest provider of mental health services and GuidanceResources® for life, today announced the honorees of the 2023 Health at Work Awards. Now in its 19th year, the ComPsych Health at Work Awards recognize organizations across a variety of sizes, industries and locations who have prioritized the health and well-being of their employees by providing innovative, multi-platform programs. “We’re thrilled to honor these stellar organizations for the investment they’ve made in building cultures that value employee mental health and wellness,” said Dr. Richard A. Chaifetz, Founder, Chairman and CEO of ComPsych. “In recent years we’ve seen a rise in anxiety as well as people needing to take leaves of absence due to mental health challenges across the workforce

U.S. Securities and Exchange Commission
Feb 12th, 2024
SEC FORM D

The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.The reader should not assume that the information is accurate and complete.

U.S. Securities and Exchange Commission
Feb 12th, 2024
SEC FORM D

The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.The reader should not assume that the information is accurate and complete.

U.S. Securities and Exchange Commission
Dec 6th, 2023
SEC FORM D

The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.The reader should not assume that the information is accurate and complete.

Home Health Provider
Feb 17th, 2023
Improving Access & Timely Care For Vulnerable Patients Referred To Home Health Via Telehealth Physician Support

Royal Philips (NYSE: PHG AEX: PHIA), a global leader in health technology, today announced the debut of its eCareManager 4.1 enterprise telehealth software at the American Telemedicine...